0.5304
price down icon4.78%   -0.0266
after-market Handel nachbörslich: .52 -0.0104 -1.96%
loading
Schlusskurs vom Vortag:
$0.557
Offen:
$0.56
24-Stunden-Volumen:
1.78M
Relative Volume:
2.90
Marktkapitalisierung:
$45.70M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.2316
EPS:
-2.29
Netto-Cashflow:
$-102.08M
1W Leistung:
-5.08%
1M Leistung:
+5.22%
6M Leistung:
-69.16%
1J Leistung:
-82.78%
1-Tages-Spanne:
Value
$0.525
$0.567
1-Wochen-Bereich:
Value
$0.525
$0.5879
52-Wochen-Spanne:
Value
$0.3418
$3.46

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
Firmenname
Century Therapeutics Inc
Name
Telefon
215-981-4000
Name
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
Mitarbeiter
165
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
IPSC's Discussions on Twitter

Vergleichen Sie IPSC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IPSC
Century Therapeutics Inc
0.5304 48.15M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-08 Eingeleitet Rodman & Renshaw Buy
2023-08-28 Herabstufung JP Morgan Overweight → Neutral
2022-12-27 Eingeleitet Chardan Capital Markets Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-05-23 Eingeleitet H.C. Wainwright Buy
2022-05-12 Eingeleitet William Blair Mkt Perform
2021-07-13 Eingeleitet BofA Securities Buy
2021-07-13 Eingeleitet JP Morgan Overweight
2021-07-13 Eingeleitet Piper Sandler Overweight
Alle ansehen

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

pulisher
May 30, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

May 30, 2025
pulisher
May 30, 2025

Q2 EPS Estimate for Century Therapeutics Raised by Analyst - Defense World

May 30, 2025
pulisher
May 29, 2025

Brokers Issue Forecasts for IPSC Q1 Earnings - Defense World

May 29, 2025
pulisher
May 28, 2025

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewswire

May 28, 2025
pulisher
May 23, 2025

Chardan Capital Issues Optimistic Forecast for IPSC Earnings - Defense World

May 23, 2025
pulisher
May 22, 2025

Leerink Partnrs Has Negative Forecast for IPSC Q2 Earnings - Defense World

May 22, 2025
pulisher
May 19, 2025

Century Therapeutics Reports Strong Q1 2025 Earnings - TipRanks

May 19, 2025
pulisher
May 19, 2025

Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline - MSN

May 19, 2025
pulisher
May 19, 2025

Chardan Trims Price Target on Century Therapeutics to $6 From $7, Maintains Buy Rating - marketscreener.com

May 19, 2025
pulisher
May 18, 2025

Chardan Capital Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $6.00 - Defense World

May 18, 2025
pulisher
May 16, 2025

Chardan Capital Lowers Price Target for Century Therapeutics (IP - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Chardan Capital Lowers Price Target for Century Therapeutics (IPSC) | IPSC Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 16, 2025
pulisher
May 15, 2025

Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates - sharewise

May 15, 2025
pulisher
May 15, 2025

Century Therapeutics Expands iPSC Cell Therapy to Europe as Q1 Revenue Surges to $109M - Stock Titan

May 15, 2025
pulisher
May 07, 2025

Marshall Wace LLP Purchases New Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 07, 2025
pulisher
May 05, 2025

JPMorgan Chase & Co. Buys 91,468 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 05, 2025
pulisher
May 02, 2025

A closer look at Century Therapeutics Inc (IPSC)’s stock price trends - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Acquires 23,413 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

May 02, 2025
pulisher
May 01, 2025

Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN

May 01, 2025
pulisher
May 01, 2025

Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Century Therapeutics (IPSC) Expected to Announce Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 30, 2025

An Analysis of Century Therapeutics Inc (IPSC)’s Potential Price Growth - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Boosts Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Market Insight: Century Therapeutics Inc (IPSC)’s Notable Drop, Closing at 0.50 - DWinneX

Apr 29, 2025
pulisher
Apr 28, 2025

Century Therapeutics to Present Preclinical Data at ASGCT 28th Annual Meeting on Novel iPSC-Derived Cell Therapies for Autoimmune Diseases and Cancer - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Century Therapeutics Reveals Groundbreaking Cancer-Fighting Cell Therapy Data at Major Scientific Conference - Stock Titan

Apr 28, 2025
pulisher
Apr 24, 2025

IPSCCentury Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK

Apr 24, 2025
pulisher
Apr 23, 2025

Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN

Apr 20, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 12,295 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by American Century Companies Inc. - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 12, 2025

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):